advanced search
2023_Terumo_leaderboard

PREFILLED SYRINGES

LAUNCHING A LARGE-VOLUME PREFILLABLE GLASS SYRINGE SYSTEM: RELIABLE SUBCUTANEOUS DRUG DELIVERY
PREFILLED SYRINGES
Isabelle Jeangoudoux
SCHOTT Pharma
LAUNCHING A LARGE-VOLUME PREFILLABLE GLASS SYRINGE SYSTEM: RELIABLE SUBCUTANEOUS DRUG DELIVERY
Isabelle Jeangoudoux and Sven Pohle introduce SCHOTT Pharma’s new syriQ BioPure 5.5 mL staked-needle prefillable glass syringe and explain how this solution meets the growing need for large-volume subcutaneous drug delivery.
ENSURING EXCELLENCE IN MANUFACTURING
PREFILLED SYRINGES
David Pircher
Baumann Medical
ENSURING EXCELLENCE IN MANUFACTURING
David Pircher, Pavel Zahradník and Maxime Ludwig discuss the medical mindset in the context of quality and present examples and tools that are used in practice.
HOW COC SYRINGES ARE SHAPING THE FUTURE OF INJECTABLE DRUG DELIVERY
PREFILLED SYRINGES
Tom Van Ginneken
Wirthwein Medical
HOW COC SYRINGES ARE SHAPING THE FUTURE OF INJECTABLE DRUG DELIVERY
Tom Van Ginneken explores the advantages of cyclo-olefin copolymer syringes, including where they outperform glass, which applications benefit most and why many common objections are outdated or debunked by current data, market adoption and technological advances.
CUSTOM METAL SOLUTIONS FOR EMERGING CHALLENGES IN AUTOINJECTOR SYSTEMS
PREFILLED SYRINGES
Iker Ibisate
RPK Medical
CUSTOM METAL SOLUTIONS FOR EMERGING CHALLENGES IN AUTOINJECTOR SYSTEMS
Iker Ibisate, Álvaro García Nograro and Irakusne Incierte, address the complex manufacturing challenges posed by increasingly sophisticated autoinjector devices and introduce RPK Medical’s approach as a technical partner in overcoming these challenges through the tailored design and manufacture of functional metal components, such as precision springs and stamped parts.
MORE THAN THE SUM OF ITS PARTS: HOW SUPPLIER COLLABORATION DRIVES SUCCESSFUL COMBINATION PRODUCTS
INJECTION
Bernd Zeiss
Gerresheimer
MORE THAN THE SUM OF ITS PARTS: HOW SUPPLIER COLLABORATION DRIVES SUCCESSFUL COMBINATION PRODUCTS
Bernd Zeiss, Lucy Lee and Sébastien Cordier discuss the multitudinous advantages of collaboration between suppliers and pharma partners, from boosting innovation to optimising component choices for device development early on, all while ensuring compliance with global regulatory standards.
SMARTER FOR BUDGETS & KINDER TO THE PLANET: ECOSAFE<sup>®</sup> SAFETY SYRINGE PLATFORM
SUSTAINABILITY
Tim Holden
Owen Mumford
SMARTER FOR BUDGETS & KINDER TO THE PLANET: ECOSAFE® SAFETY SYRINGE PLATFORM
Tim Holden describes the key objectives behind Owen Mumford’s 1 mL safety syringe injection platform and how the company sought to provide a single platform for all patients (able, less dexterous and needle-phobic) while minimising cost, waste and carbon footprint impact.
A NOVEL FORCE-MODELLING METHOD & SOFTWARE FOR ACCELERATING TIME TO MARKET FOR NEW INJECTION DEVICES
PREFILLED SYRINGES
Bradley Sawyer
Sanner Group
A NOVEL FORCE-MODELLING METHOD & SOFTWARE FOR ACCELERATING TIME TO MARKET FOR NEW INJECTION DEVICES
Bradley Sawyer, Elena Guss Tarazona,  Matthew Latham, Charlie Bowen, Dr Jay Sayed, and Harriet Field describe new software co-developed by Sanner Group and Pfizer to translate syringe test data into injection device performance, and to work backwards from device performance after shelf-life expiration to the maximum forces they can allow in a syringe test.
DE-RISKING A NOVEL VALVE COMPONENT FOR USE WITH STANDARD SYRINGE AND AUTOINJECTOR PLATFORMS
DUAL CHAMBER
Marc Flippe
BD (Becton Dickinson & Company)
DE-RISKING A NOVEL VALVE COMPONENT FOR USE WITH STANDARD SYRINGE AND AUTOINJECTOR PLATFORMS
Marc Flippe and Sophie Lelias introduce a novel valve component designed to enable dual-chamber functionality within standard syringe and autoinjector platforms. Developed through a comprehensive modelling and development framework, the BD dual-injection syringe system provides a scalable solution to dual-chamber injection that reduces the burden of change by preserving compatibility with established container formats and device architectures.
FINDING COMMON GROUND: FACTORS FOR ESTABLISHING AND SAFEGUARDING SHELF LIFE IN COMBINATION PRODUCTS
INDUSTRIALISATION
Lauren Orme
West Pharmaceutical Services
FINDING COMMON GROUND: FACTORS FOR ESTABLISHING AND SAFEGUARDING SHELF LIFE IN COMBINATION PRODUCTS
Lauren Orme discusses the regulatory considerations that need to be taken into account when designing combination products. She reviews the essential testing and standards required for both drug and device when establishing their shelf life and storage in a combined product.
MASTERING COMMERCIAL MANUFACTURING FOR STERILE INJECTABLES
EXPERT VIEW
Jennifer Gattari
MASTERING COMMERCIAL MANUFACTURING FOR STERILE INJECTABLES
Jennifer Gattari delves into what is required to succeed at the commercial phase of sterile injectable manufacturing, going on to explore the challenges that companies can expect and the critical strategies that can help ensure a smooth and scalable journey to market.
UNDERSTANDING PATIENT PREFERENCES FOR SUSTAINABLE ON-BODY DELIVERY SYSTEMS
SUSTAINABILITY
Stevanato Group
UNDERSTANDING PATIENT PREFERENCES FOR SUSTAINABLE ON-BODY DELIVERY SYSTEMS
Stevanato Group examines how semi-reusable, modular designs like its Vertiva 10 mL on-body delivery system can reconcile patient demands for ease of use with growing expectations for sustainability, sharing new UK preference data and lifecycle analysis that reveal significant waste and emissions reductions.
INTRODUCING THE TERUMO INJECTION FILTER NEEDLE – A FIRST STEP OF THE INFINO™ DEVELOPMENT PROGRAMME
INJECTION
Thomas Isaac
Terumo Medical Care Solutions
INTRODUCING THE TERUMO INJECTION FILTER NEEDLE – A FIRST STEP OF THE INFINO™ DEVELOPMENT PROGRAMME
Thomas Isaac considers the issues associated with injection to highly sensitive areas, such as the vitreous body, and the potential to optimise needle design and features to address these issues, discussing the key features of Terumo’s Injection Filter Needle, indicated for hypodermic and intravitreal injections within this context.
THE RISE OF LARGE-VOLUME SUBCUTANEOUS ADMINISTRATION OF BIOPHARMACEUTICALS, AND DELIVERY IMPLICATIONS
INJECTION
Dr Andreas Schneider
Ypsomed
THE RISE OF LARGE-VOLUME SUBCUTANEOUS ADMINISTRATION OF BIOPHARMACEUTICALS, AND DELIVERY IMPLICATIONS
Andreas Schneider and Jakob Lange consider the SC administration of larger volumes of biopharmaceuticals in the pharma industry and summarise a recent study that reviews clinical-stage and approved IV and SC biopharmaceuticals to provide valuable guidance for new product development, as well as for marketing and commercialisation strategies in the rapidly evolving large-volume SC landscape.
CONTAINER SELECTION FOR A HIGHLY SENSITIVE DRUG PRODUCT: A SUCCESS STORY
INJECTION
Enrico Barichello
Stevanato Group
CONTAINER SELECTION FOR A HIGHLY SENSITIVE DRUG PRODUCT: A SUCCESS STORY
Enrico Barichello discusses Stevanato Group’s collaboration with a leading pharmaceutical company to identify a suitable container for a high-concentration monoclonal antibody. The partnership addressed key challenges and contributed to maintaining the drug’s stability and integrity throughout its lifecycle.
DRUG DELIVERY TRENDS FOR 2025
EXPERT VIEW
Tom Oakley
DRUG DELIVERY TRENDS FOR 2025
Tom Oakley and Alex Vasiev look back at how the trends anticipated for 2024 played out in reality and look forward to four major trends expected to influence the drug delivery industry in 2025.
510(k) CLEARED, USER-FILLED MICRODOSING DEVICE FOR OPHTHALMIC AND OTHER APPLICATIONS
PREFILLED SYRINGES
Dr Gautam Shetty
Congruence Medical Solutions
510(k) CLEARED, USER-FILLED MICRODOSING DEVICE FOR OPHTHALMIC AND OTHER APPLICATIONS
Gautam Shetty discusses unmet drug delivery needs in applications requiring accurate and precise microlitre-scale doses,going on to detail how the Congruence Medical’s recently cleared Microliter Dosing Syringe can bring the benefits of advanced syringe materials and performance to these applications.
TUB & NEST – PRECISION AND EFFICIENCY IN DRUG DELIVERY
PREFILLED SYRINGES
Ivana Thiesson
Fischer Söhne
TUB & NEST – PRECISION AND EFFICIENCY IN DRUG DELIVERY
Ivana Thiesson and Jörg Sander applied marketing discuss the benefits of Fischer Söhne’s “Tub & Nest” format for packaging prefilled syringes, including design flexibility and precise cleanroom manufacturing.
TESTING SYRINGES & INJECTION DEVICES: SOLUTIONS THAT BOOST EFFICIENCY
INJECTION
Peter Schmidt
ZwickRoell
TESTING SYRINGES & INJECTION DEVICES: SOLUTIONS THAT BOOST EFFICIENCY
Peter Schmidt discusses ZwickRoell’s offerings in the arena of testing systems for injectable drug delivery systems, in particular highlighting the advantages of automation for providing reliable, reproducible results.
Interview: Sustainability at the Heart of Aptar Pharma’s Expansion
INTERVIEW
Audrey Chardonnet
Aptar Pharma
Interview: Sustainability at the Heart of Aptar Pharma’s Expansion
Audrey Chardonnet discusses the centrality of sustainability to Aptar Pharma’s expansion strategy, going into detail on how, by improving its practices and investing in its infrastructure, the company works towards reducing the environmental impact of injectable drug delivery solutions manufacturing.
DEVICE SELECTION: INJECTION VOLUMES FOR SUBCUTANEOUS ADMINISTRATION
INJECTION
Dr Nicolas Brandes
ten23 health
DEVICE SELECTION: INJECTION VOLUMES FOR SUBCUTANEOUS ADMINISTRATION
Nicolas Brandes, Andrea Allmendinger and Hanns-Christian Mahler explore the critical considerations for subcutaneous injection volume, beginning with the historical and scientific perspectives on injection volume before delving into the challenges of determining volume ranges and their associated fill volumes.
VERSATILITY, SUSTAINABILITY AND DIGITALISATION IN ONE SMART HANDHELD INJECTION PLATFORM
INJECTION
Dr Leonard Chu
Altek Medical
VERSATILITY, SUSTAINABILITY AND DIGITALISATION IN ONE SMART HANDHELD INJECTION PLATFORM
Leonard Chu discusses three trends in self-administration that are aligned with emerging smart devices – device versatility, sustainability and digitalisation – and the benefits offered by the Alcee injection platform.
BONDING TECHNOLOGIES FOR INJECTION DEVICES – A QUICK OVERVIEW
INDUSTRIALISATION
Hisham Jamal
BBS Automation
BONDING TECHNOLOGIES FOR INJECTION DEVICES – A QUICK OVERVIEW
Hisham Jamal and Carsten Köhler discuss some of the bonding technologies used for medical devices – highlighting their unique strengths, limitations and suitability.
SUBCUTANEOUS DRUG DELIVERY: ADAPTING TO HIGH-VISCOSITY, LARGE-VOLUME DEMANDS
INJECTION
Thomas Fontanellaz
Ypsomed
SUBCUTANEOUS DRUG DELIVERY: ADAPTING TO HIGH-VISCOSITY, LARGE-VOLUME DEMANDS
Thomas Fontanellaz, Reto Jost and Andreas Schneider discuss how Ypsomed is addressing the growing need for subcutaneous injections that accommodate higher volumes and viscosities, with innovative self-injection devices designed to enhance patient comfort and adherence.
STREAMLINING THE TESTING PROCESS FOR AUTOINJECTOR DEVICES
INJECTION
Landon Goldfarb
Instron
STREAMLINING THE TESTING PROCESS FOR AUTOINJECTOR DEVICES
Landon Goldfarb highlights the challenges of autoinjector testing and the importance of drawing on the experience of customers when it comes to drug delivery device innovation.
Top